ERBB2 and breast cancer: A recent study explored the oncogenic activity induced by loss of the tumor suppressor PI3K-p85α (PIK3R1): knockdown of this gene transforms human mammary epithelial cells, and its genetic ablation accelerates a mouse model of HER2/neu-driven breast cancer [289].